FDA Approved: TERIFLUNOMIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

The FDA approved Glenmark's supplemental application for teriflunomide, supporting a generic version of the multiple sclerosis therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)